Name: Women Shaping Clinical Trials
Start: 2025-03-29T18:30:00-05:00
End: 2025-03-29T20:30:00-05:00
Location: Marriott Marquis Chicago - American Book Company Building, Level 1

Join Women As One and Novo Nordisk for a discussion on becoming a trialist and the impact of diverse clinical trials.
About this Event

Women in Clinical Trials: Expanding Opportunities & Driving Diversity

Join Women As One and Novo Nordisk for an inspiring evening at ACC 2025 in Chicago! This exclusive event will dive into the status and future of diversity in clinical trials, explore pathways to becoming a trialist, and provide actionable steps for career growth.

Leading women in cardiology will share their journey as clinical trial leaders, their paths to success and the key lessons they learned throughout. Connect with peers and industry experts over engaging discussions and networking.

🎤 Featured Speakers:
✨ Moderator: Agnes Koczo, MD
✨ Panelists: Gina Lundberg, MD, Karol Watson, MD, PhD, and Malissa Wood, MD
✨ Welcome from: Women As One and Michelle Skinner Moore (VP Medical Affairs, Novo Nordisk)

📅 March 29, 6:30 - 8:30 PM CDT
📍 Marriott Marquis Chicago - American Book Company Building, Level 1

Don't miss this opportunity to grow, learn, and lead in clinical trials—register today!

🎟️ Space is limited! Secure your spot today!

Agenda

6:30 - 6:45pm: Arrival and networking

6:45 - 6:55pm: Welcome and Overview from WAO and Novo Nordisk

6:55 - 7:40pm: Panel Discussion

7:40 - 8:30pm: Networking

Do you have any questions?

Please contact Heather Mastrogiovanni at [email protected].

About the organizers

Women As One

Women As One is a non-profit organization that provides talented women cardiologists with unique professional opportunities. By supporting women cardiologists in their careers, we can shift the future of healthcare and transform women’s health. Find out more

About Novo Nordisk

Novo Nordisk is a leading global healthcare company founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases, built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. Novo Nordisk employs about 76,300 people in 80 countries and markets its products in around 170 countries. Find out more.